Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pravastatin for prevention of preeclampsia in high-risk pregnant women
IRCT20121224011862N5Phase 3Completed
- Sponsor
- Vice Chancellor for Research
- Start
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of pravastatin in preeclampsia (2 arms), sponsored by Vice Chancellor for Research. Primary endpoint: Incidence of preeclampsia. Started Sep 2022; status: completed.
02
Drugs
pravastatin
03
Conditions
preeclampsia
Beyond the preview
Go deeper on IRCT20121224011862N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20121224011862N5.